TAMPA, Fla.--(BUSINESS WIRE)--Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI), in compliance with Nasdaq Marketplace Rule 4350(b)(1)(B), which requires separate disclosure of receipt of an audit opinion that contains a going concern qualification, disclosed that its Annual Report (Form 10-K) for the fiscal year ended September 30, 2007 contains a going concern qualification from its independent registered public accounting firm, Aidman, Piser & Company, P.A. As in the past, Accentia continues to consolidate its financial statements with its majority-owned subsidiary, Biovest International, Inc., although it is not funding Biovest. This audit opinion is consistent with previous opinions included in the Company's 2005 and 2006 financial statements, which reflect the continued developmental stage of Accentia's consolidated business with Biovest.
